G

GlycoMimetics
D

GLYC

0.24300
USD
-0.01
(-2.06%)
مغلق
حجم التداول
1,100
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
15,681,298
أصول ذات صلة
A
ADMA
0.260
(1.29%)
20.420 USD
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
C
CRBP
-0.15000
(-1.99%)
7.40000 USD
REGN
REGN
-8.04
(-1.35%)
588.61 USD
R
RGNX
-0.13000
(-1.32%)
9.73000 USD
المزيد
الأخبار المقالات

العنوان: GlycoMimetics

القطاع: Healthcare
الصناعة: Biotechnology
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.